{"id":"W1946166391","doi":"10.1160/th15-02-0131","title":"Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism","year":2015,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canada Research Chairs; Bayer HealthCare; Heart and Stroke Foundation of Canada","keywords":"Rivaroxaban; Medicine; Aspirin; Antithrombotic; Anticoagulant; Incidence (geometry); Internal medicine; Randomized controlled trial; Venous thromboembolism; Surgery; Thrombosis; Anesthesia; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003216481,0.0009110447,0.00393559,0.0007069542,0.0003620212,0.001083166,0.0007967534,0.002109938,0.006413498],"category_scores_gemma":[0.00689157,0.0004955184,0.002274318,0.0004415567,0.0008331736,0.001677778,0.0004790294,0.002554812,0.0007028225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007101501,"about_ca_system_score_gemma":0.0008435124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002879446,"about_ca_topic_score_gemma":0.0005180807,"domain_scores_codex":[0.9958357,0.002679798,0.0005685493,0.0004045781,0.0002911986,0.000220293],"domain_scores_gemma":[0.9967848,0.001527498,0.0006122343,0.0002112811,0.0001233635,0.0007408248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9461048,0.006176018,0.001006837,0.000682175,0.001246425,0.00005101963,0.00005015091,0.0002867131,0.00181829,0.0004056197,0.0006511893,0.04152081],"study_design_scores_gemma":[0.7537085,0.232143,0.007099493,0.000174155,0.001570594,0.0001344779,0.00005016386,0.000863297,0.001056335,0.0008380994,0.00231417,0.00004779016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961874,0.02396517,0.001237036,0.003920532,0.00235998,0.001603004,0.0005742151,0.00009472341,0.004371397],"genre_scores_gemma":[0.9829299,0.006551594,0.002195979,0.001965314,0.001627154,0.001659897,0.0004882438,0.00001593502,0.002565886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006413498,"threshold_uncertainty_score":0.02145529,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1945961266266661,"score_gpt":0.4088974316888082,"score_spread":0.2143013050621422,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}